Complaint 3: Price Increases at Renewal Some longer-term patients report that directmeds pricing has shifted over time, particularly as compounded semaglutide supply dynamics have evolved
Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1, NEJM 2021) Jastreboff AM et al
However, not all data align
Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study
Currently, there is limited evidence on the safety and efficacy of intermittent dosing strategies, and the consensus among obesity specialists is that this approach is not generally advised except in specific clinical scenarios under close supervision
(McGraw-Hill Book Company, Sydney, 2000), pp.65671 W.J